Literature DB >> 14996738

Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer.

Yusuke Mizukami1, Jingnan Li, Xiaobo Zhang, Michael A Zimmer, Othon Iliopoulos, Daniel C Chung.   

Abstract

The induction of vascular endothelial growth factor (VEGF) is an essential feature of tumor angiogenesis, and the hypoxia-inducible factor-1 (HIF-1) transcription factor is known to be a key mediator of this process. In colon cancer, the frequently mutated K-ras oncogene also can regulate VEGF expression, but the role that K-ras may play in hypoxia is unknown. Hypoxia induced VEGF promoter activity, mRNA, and protein levels in colon cancer cells. Although HIF-1alpha was induced by hypoxia, VEGF reporter constructs with selectively mutated hypoxia-response elements remained responsive to hypoxia. In addition, "knockdown" of HIF-1alpha by RNA interference only minimally inhibited the hypoxic induction of VEGF. A region of the VEGF promoter between -420 and -90 bp mediated this HIF-independent induction by hypoxia. The introduction of K-ras(Val12) augmented the hypoxic induction of VEGF, and this was observed in wild-type and HIF-1alpha knockdown colon cancer cells. Thus, VEGF may be induced by hypoxia through HIF-dependent and HIF-independent pathways, and K-ras also can induce VEGF in hypoxia independent of HIF-1. These findings suggest the existence of multiple mechanisms regulating the hypoxic induction of VEGF in colon cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14996738     DOI: 10.1158/0008-5472.can-03-3017

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  62 in total

1.  Hypoxia-inducible factor signaling provides protection in Clostridium difficile-induced intestinal injury.

Authors:  Simon A Hirota; Kyla Fines; Jeffrey Ng; Danya Traboulsi; Josh Lee; Eikichi Ihara; Yan Li; William G Willmore; Daniel Chung; Melanie M Scully; Thomas Louie; Shaun Medlicott; Manigandan Lejeune; Kris Chadee; Glen Armstrong; Sean P Colgan; Daniel A Muruve; Justin A MacDonald; Paul L Beck
Journal:  Gastroenterology       Date:  2010-03-27       Impact factor: 22.682

Review 2.  Measuring and regulating oxygen levels in microphysiological systems: design, material, and sensor considerations.

Authors:  Kristina R Rivera; Murat A Yokus; Patrick D Erb; Vladimir A Pozdin; Michael Daniele
Journal:  Analyst       Date:  2019-05-13       Impact factor: 4.616

Review 3.  Systems biology of the microvasculature.

Authors:  Lindsay E Clegg; Feilim Mac Gabhann
Journal:  Integr Biol (Camb)       Date:  2015-04-02       Impact factor: 2.192

Review 4.  Systems biology of pro-angiogenic therapies targeting the VEGF system.

Authors:  Feilim Mac Gabhann; Amina A Qutub; Brian H Annex; Aleksander S Popel
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Nov-Dec

5.  Expression of HIF-1 alpha in human tumours.

Authors:  A Jubb; K Hillan
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

6.  Antitumoral activity of rapamycin mediated through inhibition of HIF-1alpha and VEGF in hepatocellular carcinoma.

Authors:  Wei Wang; Wei-Dong Jia; Ge-Liang Xu; Zhi-Hua Wang; Jian-Sheng Li; Jin-Liang Ma; Yong-Sheng Ge; Sheng-Xue Xie; Ji-Hai Yu
Journal:  Dig Dis Sci       Date:  2008-12-04       Impact factor: 3.199

7.  Oncogenic KRAS and BRAF differentially regulate hypoxia-inducible factor-1alpha and -2alpha in colon cancer.

Authors:  Hirotoshi Kikuchi; Maria S Pino; Min Zeng; Senji Shirasawa; Daniel C Chung
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

8.  HIF-1 alpha: a key survival factor for serum-deprived prostate cancer cells.

Authors:  Rusha Thomas; Myoung H Kim
Journal:  Prostate       Date:  2008-09-15       Impact factor: 4.104

9.  Human cancers converge at the HIF-2alpha oncogenic axis.

Authors:  Aleksandra Franovic; Chet E Holterman; Josianne Payette; Stephen Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-02       Impact factor: 11.205

10.  HIF-1alpha determines the metastatic potential of gastric cancer cells.

Authors:  N Rohwer; S Lobitz; K Daskalow; T Jöns; M Vieth; P M Schlag; W Kemmner; B Wiedenmann; T Cramer; M Höcker
Journal:  Br J Cancer       Date:  2009-02-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.